Sabra Health Care [SBRA] vs American Healthcare [AHR] Detailed Stock Comparison
Sabra Health Care
NASDAQ
Loading...
American Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sabra Health Care wins in 11 metrics, American Healthcare wins in 8 metrics, with 0 ties. Sabra Health Care appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sabra Health Care | American Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.29 | -140.93 | American Healthcare |
| Price-to-Book Ratio | 1.63 | 2.78 | Sabra Health Care |
| Debt-to-Equity Ratio | 91.74 | 69.74 | American Healthcare |
| PEG Ratio | 0.13 | -0.28 | American Healthcare |
| EV/EBITDA | 15.48 | 23.56 | Sabra Health Care |
| Profit Margin (TTM) | 24.84% | -1.53% | Sabra Health Care |
| Operating Margin (TTM) | 38.43% | 8.33% | Sabra Health Care |
| EBITDA Margin (TTM) | 38.43% | 8.33% | Sabra Health Care |
| Return on Equity | 6.66% | -1.41% | Sabra Health Care |
| Return on Assets (TTM) | 3.20% | 2.12% | Sabra Health Care |
| Free Cash Flow (TTM) | $310.54M | $84.15M | Sabra Health Care |
| Dividend Yield | 6.57% | 2.80% | Sabra Health Care |
| 1-Year Return | 17.98% | 102.19% | American Healthcare |
| Price-to-Sales Ratio (TTM) | 6.03 | 3.22 | American Healthcare |
| Enterprise Value | $6.81B | $8.52B | American Healthcare |
| EV/Revenue Ratio | 9.28 | 3.98 | American Healthcare |
| Gross Profit Margin (TTM) | 67.70% | 21.42% | Sabra Health Care |
| Revenue per Share (TTM) | $3 | $14 | American Healthcare |
| Earnings per Share (Diluted) | $0.76 | $-0.25 | Sabra Health Care |
| Beta (Stock Volatility) | 0.82 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sabra Health Care vs American Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sabra Health Care | 0.82% | 6.34% | 8.28% | 13.54% | 23.47% | 15.07% |
| American Healthcare | 1.80% | 5.17% | 12.23% | 24.32% | 55.55% | 53.08% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sabra Health Care | 17.98% | 27.24% | 30.37% | -20.76% | -23.69% | 0.62% |
| American Healthcare | 102.19% | 223.78% | 223.78% | 223.78% | 223.78% | 223.78% |
Performance & Financial Health Analysis: Sabra Health Care vs American Healthcare
| Metric | SBRA | AHR |
|---|---|---|
| Market Information | ||
| Market Cap | $4.43B | $6.89B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 3,029,470 | 1,634,670 |
| 90 Day Avg. Volume | 2,589,517 | 1,261,497 |
| Last Close | $19.62 | $42.48 |
| 52 Week Range | $15.60 - $20.03 | $19.47 - $42.54 |
| % from 52W High | -2.05% | -0.14% |
| All-Time High | $72.39 (Apr 22, 2002) | $42.54 (Aug 21, 2025) |
| % from All-Time High | -72.90% | -0.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.08% |
| Quarterly Earnings Growth | 1.73% | 4.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.25% | -0.02% |
| Operating Margin (TTM) | 0.38% | 0.08% |
| Return on Equity (TTM) | 0.07% | -0.01% |
| Debt to Equity (MRQ) | 91.74 | 69.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.31 | $14.71 |
| Cash per Share (MRQ) | $0.42 | $0.80 |
| Operating Cash Flow (TTM) | $338.84M | $254.73M |
| Levered Free Cash Flow (TTM) | $286.91M | $164.55M |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.57% | 2.80% |
| Last 12-Month Dividend | $1.20 | $1.00 |
Valuation & Enterprise Metrics Analysis: Sabra Health Care vs American Healthcare
| Metric | SBRA | AHR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.29 | -140.93 |
| Forward P/E | 27.15 | 215.16 |
| PEG Ratio | 0.13 | -0.28 |
| Price to Sales (TTM) | 6.03 | 3.22 |
| Price to Book (MRQ) | 1.63 | 2.78 |
| Market Capitalization | ||
| Market Capitalization | $4.43B | $6.89B |
| Enterprise Value | $6.81B | $8.52B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.28 | 3.98 |
| Enterprise to EBITDA | 15.48 | 23.56 |
| Risk & Other Metrics | ||
| Beta | 0.82 | N/A |
| Book Value per Share (MRQ) | $11.31 | $14.71 |
Financial Statements Comparison: Sabra Health Care vs American Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SBRA | AHR |
|---|---|---|
| Revenue/Sales | $183.54M | $540.60M |
| Cost of Goods Sold | $59.93M | $432.42M |
| Gross Profit | $123.61M | $108.18M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $67.39M | $40.27M |
| EBITDA | $111.31M | $90.88M |
| Pre-Tax Income | $40.72M | $-6.24M |
| Income Tax | $413,000 | $604,000 |
| Net Income (Profit) | $40.30M | $-6.84M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SBRA | AHR |
|---|---|---|
| Cash & Equivalents | $22.65M | $86.06M |
| Total Current Assets | $155.28M | $370.05M |
| Total Current Liabilities | $112.07M | $914.84M |
| Long-Term Debt | $2.42B | $1.19B |
| Total Shareholders Equity | $2.70B | $2.30B |
| Retained Earnings | $-1.91B | $-1.50B |
| Property, Plant & Equipment | N/A | $153.35M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SBRA | AHR |
|---|---|---|
| Operating Cash Flow | $82.99M | $36.94M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $80.26M | $39.44M |
| Debt Repayment | $-24.40M | $-92.21M |
| Common Stock Repurchase | $-5.39M | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | SBRA | AHR |
|---|---|---|
| Shares Short | 19.22M | 4.33M |
| Short Ratio | 8.24 | 3.84 |
| Short % of Float | 0.11% | 0.03% |
| Average Daily Volume (10 Day) | 3,029,470 | 1,634,670 |
| Average Daily Volume (90 Day) | 2,589,517 | 1,261,497 |
| Shares Outstanding | 237.59M | 157.45M |
| Float Shares | 235.92M | 167.10M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.01% | 0.98% |
Dividend Analysis & Yield Comparison: Sabra Health Care vs American Healthcare
| Metric | SBRA | AHR |
|---|---|---|
| Last 12-Month Dividend | $1.20 | $1.00 |
| Last 12-Month Dividend Yield | 6.57% | 2.80% |
| 3-Year Avg Annual Dividend | $1.20 | $0.42 |
| 3-Year Avg Dividend Yield | 2.11% | 1.23% |
| 3-Year Total Dividends | $3.60 | $1.25 |
| Ex-Dividend Date | May 16, 2025 | Mar 31, 2025 |